Negative and positive regulation of MAPK phosphatase 3 controls platelet-derived growth factor-induced Erk activation.
about
Simultaneous visualization of both signaling cascade activity and end-point gene expression in single cellsp-MAPK1/3 and DUSP6 regulate epididymal cell proliferation and survival in a region-specific manner in mice.Systematic quantification of negative feedback mechanisms in the extracellular signal-regulated kinase (ERK) signaling network.Dual specificity phosphatase 6 (DUSP6) is an ETS-regulated negative feedback mediator of oncogenic ERK signaling in lung cancer cells.FOXO1-dependent up-regulation of MAP kinase phosphatase 3 (MKP-3) mediates glucocorticoid-induced hepatic lipid accumulation in miceDifferential up-regulation of MAP kinase phosphatases MKP3/DUSP6 and DUSP5 by Ets2 and c-Jun converge in the control of the growth arrest versus proliferation response of MCF-7 breast cancer cells to phorbol ester.Targeting the PDGF signaling pathway in tumor treatmentSystemic perturbation of the ERK signaling pathway by the proteasome inhibitor, MG132.NR4A1 promotes PDGF-BB-induced cell colony formation in soft agarComparative microRNA profiling of sporadic and BRCA1 associated basal-like breast cancers.p38γ Mitogen-activated protein kinase signals through phosphorylating its phosphatase PTPH1 in regulating ras protein oncogenesis and stress response.Nickel nanoparticles enhance platelet-derived growth factor-induced chemokine expression by mesothelial cells via prolonged mitogen-activated protein kinase activationProtein kinase Cdelta supports survival of MDA-MB-231 breast cancer cells by suppressing the ERK1/2 pathway.The dual-specificity MAP kinase phosphatases: critical roles in development and cancer.Post-transcriptional regulation of the Ras-ERK/MAPK signaling pathway.Platelet-derived growth factor signaling in the lung. From lung development and disease to clinical studies.Exercise training decreases mitogen-activated protein kinase phosphatase-3 expression and suppresses hepatic gluconeogenesis in obese mice.Impact of oncogenic driver mutations on feedback between the PI3K and MEK pathways in cancer cells.BAG3 controls angiogenesis through regulation of ERK phosphorylation.DARPP-32 is required for MAPK/ERK signaling in thyroid cells.Signal integration and coincidence detection in the mitogen-activated protein kinase/extracellular signal-regulated kinase (ERK) cascade: concomitant activation of receptor tyrosine kinases and of LRP-1 leads to sustained ERK phosphorylation via dowNegative regulation of TGFβ signaling by the kinase LKB1 and the scaffolding protein LIP1.Assessment of SRM, MRM(3) , and DIA for the targeted analysis of phosphorylation dynamics in non-small cell lung cancer.MEK/ERK pathway mediates insulin-promoted degradation of MKP-3 protein in liver cells.Dual specificity phosphatase 5 and 6 are oppositely regulated in human skeletal muscle by acute exercise.Expression of protein-tyrosine phosphatases in Acute Myeloid Leukemia cells: FLT3 ITD sustains high levels of DUSP6 expression.Involvement of platelet-derived growth factor ligands and receptors in tumorigenesis.P2X7 Nucleotide and EGF Receptors Exert Dual Modulation of the Dual-Specificity Phosphatase 6 (MKP-3) in Granule Neurons and Astrocytes, Contributing to Negative Feedback on ERK Signaling.Identification of potentially critical differentially methylated genes in nasopharyngeal carcinoma: A comprehensive analysis of methylation profiling and gene expression profiling.Prognostic value of dual-specificity phosphatase 6 expression in non-small cell lung cancer.Dual-specificity phosphatase 6 (DUSP6): a review of its molecular characteristics and clinical relevance in cancer.Angiogenesis: Managing the Culprits behind Tumorigenesis and Metastasis
P2860
Q28744297-40C93C5A-72E3-4338-91B0-290CC695C23DQ30429887-4FBF65EF-6E9F-47B3-BA7B-91BDAEF762B8Q30497351-B0DFFD5B-B31F-4BDA-BD31-118D795FB5AFQ33759715-2AD2C4C7-7FD3-43FD-8D5E-B54C7C9280E6Q34036204-451F2B55-32ED-4780-AB16-8B37B338A939Q34074438-85F88615-A288-4564-99B7-8CF804231404Q34393461-BDBDF325-F5AC-4CB4-A6BD-13705C5F6F33Q34506190-B318A7A6-46AB-497D-9243-7BF87622A30DQ35289103-3FCCC0A1-E1FC-4D0D-987F-26413AA8323AQ35685370-8A193B99-E0D9-4990-9A65-1D8A9D264B2FQ36201947-BF53182F-59C9-4866-8561-48E7ADBA708CQ36369956-863F45E7-8215-454E-9E12-547D4B4C1654Q37446199-37B773D4-18E4-4604-8F02-861E179F2A9EQ37750129-87E6E89F-F75C-4C27-BF50-F09DF94B9775Q37891908-9196589D-5269-4A97-A6E0-44E4D097ED81Q38258904-0323FC2C-8381-42D5-9296-39AE447F4446Q38309913-E89C2177-47DE-4B0A-8FC2-1FF04AEAB3F8Q39336729-570B68D7-86E9-4C09-AF0E-46DCB9F2A350Q39400810-3295AB54-0568-441C-B97F-19816D8E4E8FQ39402299-01A47E12-51F5-4C49-B896-54AB80F8C079Q39537040-B6051C83-7FC7-4A6D-87BC-56D5EFA1B17CQ39640020-13EFFAEC-90DB-4269-94A6-12FF1047CCF8Q39739968-2D6D8115-E241-41B8-8AE8-873ECF056D44Q41965431-EDC21CEB-065A-43EF-8CFC-ECD600C4DBFEQ42378109-4A9226C1-BA1F-46F1-916E-4646F52B0497Q42515217-15D1BEF4-1576-40E9-9646-928119691208Q47756210-82E08717-E50E-40B8-9A02-A9590BAED676Q49205265-1760BCAB-70BA-495C-8603-37357426AC46Q49986892-5F75E8DC-7829-41C5-A27E-B339D7FD6CFEQ50619584-D774B531-7A74-408E-A093-2E5ED03F5AF4Q53177105-C9020B7F-C0FB-4F14-A0AF-E8649D779A6CQ57825996-106121FB-7850-4935-B5DF-E993E45D5651
P2860
Negative and positive regulation of MAPK phosphatase 3 controls platelet-derived growth factor-induced Erk activation.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Negative and positive regulati ...... factor-induced Erk activation.
@en
Negative and positive regulati ...... factor-induced Erk activation.
@nl
type
label
Negative and positive regulati ...... factor-induced Erk activation.
@en
Negative and positive regulati ...... factor-induced Erk activation.
@nl
prefLabel
Negative and positive regulati ...... factor-induced Erk activation.
@en
Negative and positive regulati ...... factor-induced Erk activation.
@nl
P2093
P2860
P356
P1476
Negative and positive regulati ...... factor-induced Erk activation.
@en
P2093
Agnieszka Gembarska
Aleksandra Jurek
Carl-Henrik Heldin
Johan Lennartsson
Kenichi Amagasaki
P2860
P304
P356
10.1074/JBC.M808490200
P407
P577
2008-12-23T00:00:00Z